MannKind Corporation Stock News

MannKind is positioned for growth with the clofazimine inhalation suspension advancing to a Phase 2/3 study and recognition of NTM infection as a global health concern. MannKind's innovative direct de

All three stocks have promising therapies that could drive revenue in the coming years.

Biotechnology has often been among the most popular sectors in the MoneyShow Top Picks report, our annual survey of the nation's leading newsletter advisors. This year's report is no exception; here's

DANBURY, Conn. and WESTLAKE VILLAGE, Calif., Jan. 05, 2023 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) a company focused on the development and commercialization of innovative therapeuti

DANBURY, Conn. and WESTLAKE VILLAGE, Calif., Jan. 05, 2023 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) a company focused on the development and commercialization of innovative therapeutic

Top stocks hit new highs. Cal-Maine broke solidly into its buy zone while biotech MannKind reached the top of its buy range.

100% technical buy signals. 14 new highs and up 23.13% in the last month.

Is it a good or bad thing when a stock experiences a golden cross technical event?

MannKind Corp's bright future sets it apart from many in the disappointing biotech industry. Strong growth in the global next-generation diabetic products market will help MannKind Corp to generate ne

WESTLAKE VILLAGE, Calif., Nov. 10, 2022 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of inhaled therapeutic products and device

WESTLAKE VILLAGE, Calif., Nov. 10, 2022 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of inhaled therapeutic products and devices

SVB Leerink raised MannKind Corporation (NASDAQ: MNKD) price target from $5 to $6. . SVB Leerink analyst Thomas Smith maintained the stock with an Outperform rating. MannKind shares rose 5% to close

B of A Securities cut the price target on Tyson Foods, Inc. (NYSE: TSN) from $73 to $61. Tyson Foods shares fell 1.9% to $66.44 in pre-market trading. Piper Sandler raised HF Sinclair Corporation

MNKD earnings call for the period ending September 30, 2022.

MannKind Corporation (NASDAQ:MNKD ) Q3 2022 Results Conference Call November 8, 2022 9:00 AM ET Company Participants Michael Castagna - Chief Executive Officer Steven Binder - Chief Financial Officer